These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 28922614

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Contribution of the MexXY multidrug efflux pump and other chromosomal mechanisms on aminoglycoside resistance in Pseudomonas aeruginosa isolates from canine and feline infections.
    Poonsuk K, Chuanchuen R.
    J Vet Med Sci; 2012 Dec; 74(12):1575-82. PubMed ID: 22813987
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Aminoglycoside resistance in Pseudomonas aeruginosa: the contribution of the MexXY-OprM efflux pump varies between isolates.
    Thacharodi A, Lamont IL.
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708991
    [Abstract] [Full Text] [Related]

  • 14. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Kafil HS, Aghazadeh M, Nikbakht M, Khalili Y.
    J Infect Public Health; 2018 Jun; 11(3):364-372. PubMed ID: 28993173
    [Abstract] [Full Text] [Related]

  • 15. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.
    Antimicrob Agents Chemother; 2009 May; 53(5):1987-97. PubMed ID: 19258280
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR, Nahaei MR, Rezaee MA, Hasani A, Samadi Kafil H, Aghazadeh M, Sheikhalizadeh V.
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [Abstract] [Full Text] [Related]

  • 18. Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa.
    Kiser TH, Obritsch MD, Jung R, MacLaren R, Fish DN.
    Pharmacotherapy; 2010 Jul; 30(7):632-8. PubMed ID: 20575627
    [Abstract] [Full Text] [Related]

  • 19. Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa.
    Bolard A, Plésiat P, Jeannot K.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [Abstract] [Full Text] [Related]

  • 20. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K, Gilmour C, Farha MA, Parkins MD, Klinoski R, Brown ED.
    J Antimicrob Chemother; 2018 May 01; 73(5):1247-1255. PubMed ID: 29420743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.